Discovering new treatments for cancer-associated cognitive impairment


Cognitive impairment is extremely common among cancer patients and survivors. The Laboratory of ImmunoPsychiatry has determined that the cancer itself contributes to this using animal models of breast cancer, which may be prevented by the use of anti-inflammatory drugs. We are now trying to determine the precise biological changes that occur in the brains of cancer patients that lead to long-term cognitive impairment and identify novel treatment strategies that can be tested in clinical populations from diagnosis through to the end of treatment.


Expertise & facilities


GIVING DAY 2024 – DOUBLE YOUR IMPACT

Please donate for our first-ever GIVING DAY on 10 April — and your generous gift to support life-changing research into brain and nervous system disorders will be DOUBLED. 

Click here to donate now